PharmaNet appoints George Scott VP
This article was originally published in Scrip
Executive Summary
PharmaNet Development Group, an inVentiv Health Company and provider of clinical development services, has appointed Dr George Scott vice-president of bioanalytical services. Previously, Dr Scott served as director of pharmacokinetics and drug metabolism at Amgen where he was responsible for overseeing the immunochemistry and small molecule bioanalytical capabilities.